These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12187312)

  • 1. Interactions between hypercholesterolemia and hypertension: implications for therapy.
    Borghi C
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):489-96. PubMed ID: 12187312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins in hypertension: are they a new class of antihypertensive agents?
    Feldstein CA
    Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids, blood pressure and kidney update 2014.
    Banach M; Aronow WS; Serban C; Sahabkar A; Rysz J; Voroneanu L; Covic A
    Pharmacol Res; 2015; 95-96():111-25. PubMed ID: 25819754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond lipid lowering: the anti-hypertensive role of statins.
    Chopra V; Choksi PU; Cavusoglu E
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):161-9. PubMed ID: 17468937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
    Sirenko Y; Radchenko G;
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):85-93. PubMed ID: 28150140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive lipid therapy in the statin era.
    Farmer JA
    Prog Cardiovasc Dis; 1998; 41(2):71-94. PubMed ID: 9790411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
    Stefanutti C; Morozzi C; Di Giacomo S
    Curr Med Chem; 2012; 19(28):4861-8. PubMed ID: 22963620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined antihypertensive and lipid-lowering treatment.
    Cesari M; Pessina AC
    Curr Hypertens Rep; 2004 Aug; 6(4):300-6. PubMed ID: 15257865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
    Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practice.
    Prandin MG; Cicero AF; Dormi A; Veronesi M; Cosentino ER; Borghi C
    Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):512-8. PubMed ID: 19699070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of statins in the management of atherosclerosis.
    Vaughan CJ; Gotto AM; Basson CT
    J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient at intermediate cardiovascular risk: statins, yes! - antihypertensive therapy, maybe.
    Volpe M; Costanzi V
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e130-e132. PubMed ID: 29538162
    [No Abstract]   [Full Text] [Related]  

  • 16. Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Ruland S; Gorelick PB
    Curr Atheroscler Rep; 2003 Jan; 5(1):38-43. PubMed ID: 12562541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond statins: lipid management to reduce cardiovascular risk.
    Schuck RN; Mendys PM; Simpson RJ
    Pharmacotherapy; 2013 Jul; 33(7):754-64. PubMed ID: 23606278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.
    Di Martino M; Degli Esposti L; Filigheddu F; Veronesi C; Salerno G; Saragoni S; Glorioso N; Didoni G; Degli Esposti E
    J Hum Hypertens; 2007 Jan; 21(1):53-9. PubMed ID: 17036042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives on statins.
    Maron DJ; Fazio S; Linton MF
    Circulation; 2000 Jan; 101(2):207-13. PubMed ID: 10637210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension.
    Borghi C; Dormi A; Veronesi M; Immordino V; Ambrosioni E
    J Clin Hypertens (Greenwich); 2002; 4(4):277-85. PubMed ID: 12147931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.